Through its bank subsidiary, Franklin Synergy Bank, the Company provides a range of banking and related financial services within the Nashville metropolitan area.This alert was triggered by Franklin’s high average earnings per share growth rate of 20% over the past five years, compared to... Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
At some point not enough bogeymen exist to justify keeping the U.S. economy from operating under normal conditions.But on the heels of July’s surprisingly strong employment report, Fed chair Janet Yellen may feel compelled to raise interest rates next month if the rest of the economy remains on track. Inflation is also… Read More
On August 10th Argos Therapeutics (NasdaqGM: ARGS) released its second quarter earnings report, which in terms of financial performance was about what everyone expected. Although earnings came in worse than expected at a loss of 48 cents versus the analysts’ estimate of minus 40 cents, it beat on its… Read More
It was the best of Apples, it was the worst of Apples—depending on what type of investor you are. At the same time a high-profile hedge fund manager was reducing his position in Apple during the second quarter of this year, legendary investor Warren Buffett was increasing his stake by 55%. Read More
- August 18, 2016
-
Download Issue
This highly priced stock is ripe for a bet that its share price will fall. Read More
- August 18, 2016
-
Download Issue
Innogration is key for putting firms on a track to change and success. Read More
As we noted in last week’s alert, Ekso Bionics (EKSO) announced last Tuesday that it would raise additional capital by issuing 3.75 million new shares of common stock at a price of $4.00 per share. On Friday, the company confirmed that it had successfully closed that offering, generating… Read More
Myriad Genetics is a molecular diagnostic company. This alert was triggered by Myriad’s undervalued balance sheet, which includes assets of $242 million while carrying no long term debt. The company has grown earnings-per-share by 215% over the past ten years, yet... Read More
This morning Ekso Bionics Holdings (EKSO) announced it will raise $15 million via a secondary offering of 3,750,000 million shares of common stock at a price of $4.00 per share. This announcement was accompanied by confirmation that the company’s stock has been approved for listing on the Nasdaq Capital… Read More
It was just five weeks ago that the two stocks highlighted in my June 17th article, “Top Tech Takeover Targets”, Applied Optoelectronics (AAOI) and Synaptics (SYNA), popped in value thanks to unexpected good news. In the case of Applied Optoelectronics, that news was in the form of an endorsement… Read More